Skip to content

Effect of Bread With Nigella Sativa on Blood Factors in Metabolic Syndrome Patients

Effect of Bread With Nigella Sativa on Lipid Profiles, Apolipoproteins, Inflammatory Factors and Coagulatory Factors in Metabolic Syndrome Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015041821815N1
Enrollment
48
Registered
2015-06-30
Start date
2015-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Metabolic Syndrome. Condition 2: Obesity. - Obesity

Interventions

Intervention 1: It is prepared for intervention group to use a 100 grams dietetic bread with nigella sativa(3 grams) and having a balanced diet with decreasing 10 percent in dietary energy for 2 mont
Lifestyle
It is prepared for intervention group to use a 100 grams dietetic bread with nigella sativa(3 grams) and having a balanced diet with decreasing 10 percent in dietary energy for 2 months.
It is prepared for control group to use a 100 grams dietetic bread and having a balanced diet with decreasing 10 percent in dietary energy for 2 months.

Sponsors

Isfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria :Having 3 Items of 5 Items of Metabolic Syndrome :Waist Circumference over 102 for Men and over 88 Centimeter for Women, Serum Triglycerid 150 mg/dl or More or Using of Drug , Serum HDL under 40 for Men and under 50 for Women, Fasting Blood Sugar 100 mg/dl or More or Using of Drug , Blood Presure 130/85 or More or Using of drug. Exclusion Criteria :Change in Type or Dosage of Drug or Supplements in Medical Therapy,Pregnancy,Having Chronic Diseases in Liver, kidney, Neural and musclelar system.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Blood Parameters. Timepoint: Before and After Intervention ( as Crossover Design ). Method of measurement: Evaluation of Blood Parameters with Lab Technics.

Secondary

MeasureTime frame
Medical and Body Parameters (Blood Pressure, Weight, Waist Circumference). Timepoint: Before and After Intervention (as Crossover Design). Method of measurement: Measuring of Blood Pressure with Sphygmomanometer, Measuring of Waist Circumference with Meter, Measuring of Weight with Balance Divice.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Mohtashami

Isfahan University of Medical Sciences

mohtashami_52@yahoo.com+98 31 3792 2752

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 22, 2026